Extracellular matrix regulates endothelial functions through interaction of VEGFR-3 and integrin alpha5beta1.
about
Tetraspanin CD63 promotes vascular endothelial growth factor receptor 2-β1 integrin complex formation, thereby regulating activation and downstream signaling in endothelial cells in vitro and in vivoDevelopment of the mammalian lymphatic vasculatureReceptor tyrosine kinase-mediated angiogenesisMechanoinduction of lymph vessel expansion.Slit2/Robo4 signaling modulates HIV-1 gp120-induced lymphatic hyperpermeability.Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1Lymphangiogenesis and lymphatic metastasis in breast cancer.Integrin-α5β1 is not required for mural cell functions during development of blood vessels but is required for lymphatic-blood vessel separation and lymphovenous valve formation.Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathwayPredictive value of tumor recurrence using urinary vascular endothelial factor levels in patients receiving radiation therapy for Glioblastoma Multiforme (GBM)AKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation.Combined blockade of VEGFR-3 and VLA-1 markedly promotes high-risk corneal transplant survival.Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation.Endothelial Snail Regulates Capillary Branching Morphogenesis via Vascular Endothelial Growth Factor Receptor 3 ExpressionMolecular regulation of lymphangiogenesis in development and tumor microenvironment.BRAF Inhibition Generates a Host-Tumor Niche that Mediates Therapeutic Escape.Pathological lymphangiogenesis is modulated by galectin-8-dependent crosstalk between podoplanin and integrin-associated VEGFR-3.Strategies and techniques to enhance the in situ endothelialization of small-diameter biodegradable polymeric vascular graftsalpha5beta1 Integrin blockade inhibits lymphangiogenesis in airway inflammation.Integrin and growth factor receptor alliance in angiogenesis.Lymphatic development.Thrombin induces fibronectin-specific migration of pulmonary microvascular endothelial cells: requirement of calcium/calmodulin-dependent protein kinase IIMechanism of lymph node metastasis in prostate cancer.Interaction between the extracellular matrix and lymphatics: consequences for lymphangiogenesis and lymphatic functionIntegrin α5β1 simultaneously controls EGFR-dependent proliferation and Akt-dependent pro-survival signaling in epidermoid carcinoma cells.Therapeutic potential of novel modulators of neovascularization.Kaposi's sarcoma-associated herpesvirus activation of vascular endothelial growth factor receptor 3 alters endothelial function and enhances infection.Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockade.Integrins in tumor angiogenesis and lymphangiogenesis.Deletion of tetraspanin CD9 diminishes lymphangiogenesis in vivo and in vitro.Integrin alpha9beta1 directly binds to vascular endothelial growth factor (VEGF)-A and contributes to VEGF-A-induced angiogenesis.Lymphangiogenesis guidance by paracrine and pericellular factors.Mast Cells Interact with Endothelial Cells to Accelerate In Vitro Angiogenesis.Molecular Regulation of Sprouting Angiogenesis.Biology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic Vessels.Developmental Pathways Pervade Stem Cell Responses to Evolving Extracellular Matrices of 3D Bioprinted Microenvironments.
P2860
Q24339486-F83E88D4-7998-46DC-AF52-A488819BD43DQ26852649-72192610-22F7-4E93-AED7-580DC1174E66Q27001612-CB6A67AC-BE3F-460C-BEF4-9ED3BB506F5FQ30505376-2AAF138C-253C-4503-9C47-0538F9AF0B12Q31044936-E7F08480-E208-485A-8F8E-F2DD8B909D6DQ33884989-1948C6CF-F6C7-430B-99F1-840069FE9EBDQ33940058-DFB7D76D-6153-47DF-B172-A9E66C3C549AQ33963025-499CA689-27EC-4E41-BA06-E287231057D0Q34003819-C67FDC91-622F-4F02-B38A-CDEF7C82C28FQ34256198-76D13EE7-3BAA-4EFC-BD7D-90B5BD474E9AQ35196528-6BCA2006-9C8A-48C8-AE2A-945C4388FFA7Q35221271-7EC21511-C141-4A13-ABD6-ADC22B37E3A5Q35574091-1999EE1E-67ED-4056-A14A-D6E8BD381D3DQ35683653-CE97DA68-EBE6-4A5F-9442-F258BE74598CQ36284953-59C6BEC3-47E1-47C4-A973-BF0EFF631D57Q36289114-B8CD735D-C1B9-4727-A997-0AD949A0C940Q36799205-A024E5CE-1264-4AA7-BBC4-3DBE7E71743EQ36948086-B0DF97EA-B1B3-4568-A13C-1F1F996AB149Q37197423-985D77DC-45FF-4E34-B9B0-06B3D838247FQ37339044-A91ED596-B48F-4F35-AB02-03337A943873Q37371437-0CCD7EE1-A649-49A2-8629-A7BF2BDE5BD5Q37406387-A641CC09-63D3-440B-BD55-3672576F08BDQ37750801-86ECC5A4-B4CC-43AD-8B6B-D3343D1CEC1CQ37781426-4077A84A-A8A4-49DC-BDC4-56BBF89B5E4FQ39342816-9C27F2E5-4DDA-40AA-BB69-D428149BFB03Q40076736-B262E0EE-7595-40AB-AC5D-C95A845E9C01Q40425763-C4F9A092-1B60-411D-A6B9-580517E7E85EQ42046458-50BAD16F-6B17-4FCD-9CAA-9C2AF4F060C5Q42263292-F0570BB8-2EDD-49E8-8DFB-0CAD9992B043Q42973720-91403D1D-3475-43DF-9C7E-58D617748658Q46220745-25CC41D2-6BC7-47E2-8A93-16373D326018Q47744569-0F8C6DEC-4E47-44FF-B699-B55D366A5106Q48125931-0B2F2387-9AEE-492E-83A9-082F4EB02128Q50423780-EA288803-0C07-4595-9061-B1C59B41A194Q54985404-BBCCB5D8-75B8-4A6C-937E-8A93509AEAFAQ55053269-872BCA4C-89D0-46C3-9439-8CEF95B86314
P2860
Extracellular matrix regulates endothelial functions through interaction of VEGFR-3 and integrin alpha5beta1.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Extracellular matrix regulates ...... FR-3 and integrin alpha5beta1.
@en
Extracellular matrix regulates ...... FR-3 and integrin alpha5beta1.
@nl
type
label
Extracellular matrix regulates ...... FR-3 and integrin alpha5beta1.
@en
Extracellular matrix regulates ...... FR-3 and integrin alpha5beta1.
@nl
prefLabel
Extracellular matrix regulates ...... FR-3 and integrin alpha5beta1.
@en
Extracellular matrix regulates ...... FR-3 and integrin alpha5beta1.
@nl
P2093
P2860
P356
P1476
Extracellular matrix regulates ...... FR-3 and integrin alpha5beta1.
@en
P2093
Jerome E Groopman
Jian Feng Wang
Xuefeng Zhang
P2860
P304
P356
10.1002/JCP.20106
P577
2005-01-01T00:00:00Z